RESEARCH HIGHLIGHT
A nationally recognized leader in Type 1 diabetes (T1D) research, Emily K. Sims, MD, a physician-scientist at Riley Children’s Health, has been on the ground floor of some of the most notable advancements in T1D treatment and prevention in the past 15 years.
>
READ about Dr. Sims and Riley’s long-standing participation in groundbreaking clinical trials for T1D.
PIONEERS “While we’ve come a long way in how we administer insulin and monitor blood sugar in patients with T1D, our current focus is how we can treat the disease by targeting its underlying cause. If we can find a regimen that could be given before symptoms develop—that would help preserve insulin-producing cells and delay the need for insulin replacement—the disease will be easier to manage and patients could have better long-term outcomes.”
Emily K. Sims, MD Pediatric endocrinologist and researcher Associate Professor of Pediatrics, IU School of Medicine > Connect with Dr. Sims on Doximity.
An active clinical trial site for therapies designed to modify the course of T1D, Riley Children’s is one of just 17 centers in the world participating in TrialNet , a major research network focused on T1D prevention. > Learn more about our program.
DIABETES & ENDOCRINOLOGY AT RILEY CHILDREN’S
Made with FlippingBook flipbook maker